Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Immunity Bio up 400% in a month

<< Previous

Bullboard Posts

Next >>

Comment by ScienceFirston May 08, 2023 4:13pm

214 Views

Post# 35437145

RE:RE:RE:Immunity Bio up 400% in a month

NP ... Because that would be a jv, as opposed to a buyout, you only have to consider TSO (total shares outstanding) in the valuation calculation. So not fully diluted.

So 2.7B$US / 216 TSO shares = 12.5$US/share (16.25$CAN).

But in the case of ImmunityBio, that would be a full approval. So entitled to get revenues. We're not there yet as we only aim for BDT for the moment. But that would be a start, as BDT would put the hilighted on us. Then, hopefully AA and a jv.

We must not forget that a pp would increase the TSO. But nevertheless, still lots of upside potential if everything unfolds correctly.

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?